In mice, inhibition of HMGB1 activity via antibody targeting revealed a protective effect against lipopolysaccharide (LPS) lethality, whereas increasing HMGB1 activity resulted in worsened endotoxemia and LPS lethality (7). This evidence concerns the gene HMGB1 and serum lipopolysaccharide activity.